Elevance Health Inc (ELV) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.098x

Based on the latest financial reports, Elevance Health Inc (ELV) has a cash flow conversion efficiency ratio of 0.098x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($4.33 Billion) by net assets ($44.04 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ELV market cap for the company's overall valuation and market capitalisation.

Elevance Health Inc - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how Elevance Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Elevance Health Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Elevance Health Inc ranked by their cash flow conversion efficiency. Explore cash flow quality index of Elevance Health Inc to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Williams Companies Inc
NYSE:WMB
0.106x
KKR & Co. Inc.
NYSE:KKR
0.024x
Intuit Inc
NASDAQ:INTU
0.257x
PNC Financial Services Group Inc
NYSE:PNC
0.030x
National Grid PLC ADR
NYSE:NGG
0.088x
Eoptolink Technology Inc Ltd
SHE:300502
0.180x
Midea Group Co Ltd
SHE:000333
0.098x
Tata Consultancy Services Limited
NSE:TCS
0.111x

Annual Cash Flow Conversion Efficiency for Elevance Health Inc (2000–2025)

The table below shows the annual cash flow conversion efficiency of Elevance Health Inc from 2000 to 2025. View Elevance Health Inc (ELV) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $44.03 Billion $4.29 Billion 0.097x -30.50%
2024-12-31 $41.43 Billion $5.81 Billion 0.140x -31.46%
2023-12-31 $39.41 Billion $8.06 Billion 0.205x -11.51%
2022-12-31 $36.33 Billion $8.40 Billion 0.231x -0.14%
2021-12-31 $36.13 Billion $8.36 Billion 0.232x -28.09%
2020-12-31 $33.20 Billion $10.69 Billion 0.322x +68.53%
2019-12-31 $31.73 Billion $6.06 Billion 0.191x +42.47%
2018-12-31 $28.54 Billion $3.83 Billion 0.134x -15.08%
2017-12-31 $26.50 Billion $4.18 Billion 0.158x +23.68%
2016-12-31 $25.10 Billion $3.20 Billion 0.128x -28.52%
2015-12-31 $23.04 Billion $4.12 Billion 0.179x +28.56%
2014-12-31 $24.25 Billion $3.37 Billion 0.139x +12.72%
2013-12-31 $24.77 Billion $3.05 Billion 0.123x +6.89%
2012-12-31 $23.80 Billion $2.74 Billion 0.115x -20.42%
2011-12-31 $23.29 Billion $3.37 Billion 0.145x +143.55%
2010-12-31 $23.81 Billion $1.42 Billion 0.059x -51.32%
2009-12-31 $24.86 Billion $3.04 Billion 0.122x +3.32%
2008-12-31 $21.43 Billion $2.54 Billion 0.118x -37.40%
2007-12-31 $22.99 Billion $4.34 Billion 0.189x +14.84%
2006-12-31 $24.58 Billion $4.04 Billion 0.165x +26.29%
2005-12-31 $24.99 Billion $3.26 Billion 0.130x +94.57%
2004-12-31 $19.46 Billion $1.30 Billion 0.067x -64.86%
2003-12-31 $6.00 Billion $1.14 Billion 0.191x +3.11%
2002-12-31 $5.36 Billion $991.10 Million 0.185x -41.84%
2001-12-31 $2.06 Billion $654.60 Million 0.318x -10.88%
2000-12-31 $1.92 Billion $684.50 Million 0.357x --

About Elevance Health Inc

NYSE:ELV USA Healthcare Plans
Market Cap
$89.59 Billion
Market Cap Rank
#305 Global
#159 in USA
Share Price
$412.56
Change (1 day)
-1.19%
52-Week Range
$280.74 - $426.79
All Time High
$560.60
About

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad… Read more